Gavin Pinkston
Family Medicine · Columbia, TNNPI 1013238856
Payments from drug & device makers
Across 386 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$636
- AbbVie$554
- Boehringer Ingelheim$533
- Novo Nordisk$466
- Johnson & Johnson$450
- Lilly USA, LLC$380
- plus $3K from 37 others
What the payments were for
- Food & beverage$6,40799%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,492 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 82 | $51,793 |
| OzempicSemaglutide | 22 | $31,782 |
| MounjaroTirzepatide | 26 | $26,801 |
| TrulicityDulaglutide | 21 | $23,795 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $17,094 |
| FarxigaDapagliflozin Propanediol | 18 | $16,727 |
| JanuviaSitagliptin Phosphate | 18 | $14,303 |
| Emgality PenGalcanezumab-Gnlm | 17 | $12,839 |
| Xigduo XrDapaglifloz Propaned/Metformin | 12 | $6,872 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $6,865 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $4,799 |
| Dexlansoprazole DrDexlansoprazole | 23 | $4,517 |
| Novolog FlexpenInsulin Aspart | 12 | $4,030 |
| Atorvastatin Calcium | 345 | $3,278 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 70 | $2,758 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $365 | $51,79382 claims |
| Lilly USA, LLCMounjaro, Trulicity | $380 | $50,59647 claims |
| Novo NordiskOzempic | $466 | $31,78222 claims |
| MerckJanumet, Januvia | $82 | $31,39729 claims |
| AstraZenecaFarxiga, Symbicort | $636 | $21,52636 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $12 | $2,283192 claims |
| AbbVieSynthroid | $554 | $1,56522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Columbia
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
- Marcus LeeTullahoma$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.